NUNZIUM

News That Matters

16/10/2023 ---- 18/10/2023

In India, the world's largest democracy, the fight for marriage equality is a pressing issue. The plight of same-sex couples, such as Aditi Anand and Susan Dias from Mumbai, exemplifies the struggle against legal barriers that deny millions of LGBTQ couples the right to marry. These laws prevent them from adopting, accessing insurance, and inheriting property as a couple.

The battle for marriage equality has escalated to India's Supreme Court, with a landmark case challenging the country's law against same-sex marriage since April. The case, brought by 18 petitioners including Anand and Dias, advocates for equal treatment of the LGBTQ community under India's constitution. However, the ruling Bharatiya Janata Party (BJP) government argues that same-sex marriage is a "Western" concept without any constitutional basis, labeling it an "urban" and "elitist" concept. This argument dismisses the presence of gender transformations and third-gender characters in Hindu mythology and overlooks the fact that the criminalization of same-sex intercourse and the limitation of marriage rights were introduced by British colonial leaders in 1860.

Progress has been made in the fight for LGBTQ rights in India. In 2018, the Supreme Court decriminalized same-sex intercourse, a colonial-era law. However, the law limiting marriage to heterosexual couples remained. Despite this, same-sex relationships have gained acceptance in Bollywood and major cities like Mumbai and Bengaluru.

The court's upcoming ruling could significantly impact the conservative country, potentially legitimizing and empowering countless Indians struggling with their sexuality and facing harassment. Anish Gawde, founder of Pink List India, underscores the importance of marriage equality for tens of thousands of queer individuals in India facing societal stigma and oppression.

However, the Supreme Court recently declined to grant legal recognition to same-sex marriages, stating that such decisions should be made by parliament. This ruling disappointed the LGBTQ+ community, who had hoped for the recognition of their constitutional right to marriage equality. The five-judge bench was divided, with two judges supporting same-sex civil unions, but the majority verdict ruled against them.

Despite the ruling, the chief justice of India, DY Chandrachud, emphasized that LGBTQ+ individuals should have the right to choose their partners and co-habit without discrimination. He instructed the government to form a high-level committee to examine the concerns, rights, and welfare entitlements of same-sex couples. This ruling, while disappointing, still advances LGBTQ+ rights in some ways, according to Supreme court lawyer Karuna Nundy.

The Supreme Court is set to rule on petitions demanding legal recognition for same-sex marriages. The verdict was reserved on May 11 after a 10-day hearing in March and April. The petitioners are challenging the constitutionality of provisions of the Special Marriage Act, Hindu Marriage Act, Foreign Marriage Act, and other marriage laws, arguing they deny same-sex couples the right to marry.

The battle for love and equality continues in India. If the petitioners succeed, India will become the third country in Asia to allow same-sex unions, marking a significant milestone in the fight for LGBTQ rights. As Anand and Dias stress, their fight for marriage equality is not just for themselves, but for the millions of people who don't have the means to fight, uniting India's LGBTQ community in their shared struggle for recognition and equality.

READ MORE

The al-Ahli Hospital in Gaza City recently experienced a devastating explosion, resulting in approximately 500 casualties. The cause of the explosion is disputed, with the Hamas-run Health Ministry in Gaza attributing it to an Israeli airstrike, a claim Israel's military refutes, pointing instead to a misfired Palestinian rocket. The truth, like peace, seems elusive amidst the debris and smoke of the devastated hospital.

Simultaneously, the Palestinian Authority (PA), established in 1994, is facing significant opposition. A September poll revealed that 78% of Palestinians want PA President Mahmoud Abbas to resign, and support for Hamas is growing. The PA's struggle is not just political; it is also physical. Despite receiving US-made weapons and armored vehicles in an attempt to regain control over the West Bank, Israeli military operations resulted in the arrest of 280 Palestinians, including 157 Hamas members.

As political instability continues, the humanitarian crisis in Gaza intensifies. The United Nations reports that Israel's tight siege is exacerbating the situation, leaving tens of thousands of Palestinians in desperate need of basic necessities. In response to Hamas attacks, the Israeli military continues its bombardment of the Gaza Strip.

The repercussions of the Israel-Palestine conflict are far-reaching, impacting the global energy sector. Chevron Corp had to suspend production at the Tamar natural gas field near Israel's northern coast due to the conflict, causing a surge in European gas prices. The field, responsible for 70% of Israel's energy needs, has over 300 billion cubic meters of gas, equivalent to annual European gas imports. A prolonged shutdown could disrupt Israeli gas exports to Egypt, which subsequently exports gas to Europe.

In France, President Emmanuel Macron is taking measures against radicalism following the murder of a teacher in Arras by a former student with a history of Islamic radicalisation. Macron has ordered a review of foreigners with a record of radicalism for possible expulsion, a controversial move that demonstrates France's commitment to combating terrorism.

Across the Atlantic, Hollywood stars are expressing solidarity with Israel in response to large-scale terrorist attacks by Hamas. Under the hashtag #standwithisrael, 700 stars, including Gal Gadot and Michael Douglas, signed an open letter condemning the Hamas assault. This stance is mirrored in several German cities, signifying a global denunciation of the violence.

READ MORE

A groundbreaking study led by the Institute of Cancer Research in London, the Royal Marsden NHS Foundation Trust, and the Institute of Oncology Research in Switzerland, has unveiled a promising strategy to overcome prostate cancer's resistance to treatment. This pioneering research holds significant potential for the over a million men diagnosed with prostate cancer globally each year.

Cancer cells are notoriously adept at evading treatment. They manipulate the immune system to resist drugs, but this study found a way to thwart these rogue cells. By blocking the cells' covert messages that co-opt healthy white blood cells, the researchers were able to resensitize a subset of advanced cancer, leading to the shrinkage or cessation of tumor growth. This innovative approach, published in the scientific journal Nature, focuses on the "feeder" myeloid white blood cells that tumors use to fuel their growth.

The study involved patients with advanced prostate cancer that had become resistant to conventional hormone therapy. The patients were treated with a combination of an experimental drug, AZD5069, which prevents myeloid cell recruitment to tumors, and enzalutamide, a standard hormone therapy. The results were promising: out of 21 patients, five, or 24%, responded positively. Their tumors shrank by more than 30%, and they experienced significant decreases in prostate-specific antigen (PSA) levels, a key marker of prostate cancer. Additionally, their blood levels of circulating tumor cells, a sign of the cancer's progression, also dropped significantly.

This research is the culmination of a decade of tireless work by the team, investigating how myeloid cells contribute to prostate cancer's growth. The study was funded by a consortium of organizations including Prostate Cancer UK, Cancer Research UK, the Swiss Card Onco grant organization, the Prostate Cancer Foundation, AstraZeneca, Wellcome, and the NIHR Biomedical Research Centre at the Royal Marsden and ICR.

The medical community has warmly welcomed this breakthrough, with plans for a clinical trial based on these findings already in motion. Dr Matthew Hobbs, Prostate Cancer UK’s director of research, has urged pharmaceutical companies to collaborate with researchers to develop new drugs based on this research and test them in larger trials.

This research could potentially extend beyond prostate cancer, offering a new approach to treat other types of cancer. As we enter a new era in cancer treatment, this study paves the way towards more effective, targeted treatments, bringing us a step closer to a turning point in the battle against prostate cancer.

READ MORE